The Patent Finder

Terms ending in 2034

CureVac AG

Every in-force patent on CureVac AG's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,117,920Combination of Vaccination and Inhibition of the PD-1 Pathway
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 10,434,158Combination of Vaccination and Inhibition of the PD-1 Pathway
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 11,458,195Combination of Vaccination and Inhibition of the PD-1 Pathway
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 12,447,209Combination of Vaccination and Inhibition of the PD-1 Pathway
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 10,307,472Combination of Vaccination and OX40 Agonists
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 11,110,157Combination of Vaccination and OX40 Agonists
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 9,737,595Combination of Vaccination and Inhibition of MHC Class I Restricted Antigen Presentation
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 9,688,729Respiratory Syncytial Virus (RSV) Vaccine
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 10,150,797Respiratory Syncytial Virus (RSV) Vaccine
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 10,293,060Method for Increasing Expression of RNA-Encoded Proteins
In force
 · High confidence
Curevac SEIn forceHigh confidence
14 more term ends in 2034 · Pro
10 of 24 patents shown. Soonest term end first, then patent number.
Pro members see all 24.
Upgrade to Pro
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited